The Impact of Frailty on the Relationship between Life-Space Mobility and Quality of Life in Older Adults During the COVID-19 Pandemic

Imagem de Miniatura
Arquivos
art_SARAIVA_The_Impact_of_Frailty_on_the_Relationship_between_2021.PDF (701.36 KB)
Citações na Scopus
46
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER FRANCE
Autores
YAMAGUTI, S. Tavares Fernandes
Citação
JOURNAL OF NUTRITION HEALTH & AGING, v.25, n.4, p.440-447, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The COVID-19 pandemic has led to abrupt restrictions of lile-space mobility. The impact of shelter-in-place orders on older adults' health and well-being is still unclear. Objective To investigate the relationship between life-space mobility and quality of life (QoL) in older adults with and without frailty during the COVID-19 pandemic. Design Multicenter prospective cohort study based on structured telephone interviews. Setting Four geriatric outpatient clinics in the metropolitan area of Sao Paulo, Brazil. Participants 557 community-dwelling adults aged 60 years and older. Measurements The Life-Space Assessment was used to measure community mobility before and during the COVID-19 pandemic, and a previously validated decrease of >= 5 points defined restricted life-space mobility. Frailty was assessed through the FRAIL (fatigue, resistance, ambulation, illnesses, and loss of weight) scale. The impact of shelter-in-place orders on QoL was evaluated with the question << How is the COVID-19 pandemic affecting your QoL?>>, to which participants could respond << not at all >>, << to some extent >>, or << to a great extent >>. We used ordinal logistic regressions to investigate the relationship between restricted life-space mobility and impact on QoL, adjusting our analyses for demographics, frailty, comorbidities, cognition, functionality, loneliness, depression, and anxiety. We explored whether frailty modified the association between life-space mobility and impact on QoL. Results Participants were on average 80 +/- 8 years old, 65% were women, and 33% were frail. The COVID-19 quarantine led to a restriction of community mobility in 79% of participants and affected the QoL for 77% of participants. We found that restricted life-space mobility was associated with impact on QoL in older adults during the pandemic, although frailty modified the magnitude of the association (P-value for interaction=0.03). Frail participants who experienced restricted life-space mobility had twice the odds of reporting an impact on QoL when compared with non-frail individuals, with respective adjusted odds ratios of 4.20 (95% CI=2.36-7.50) and 2.18 (95% CI=1.33-3.58). Conclusion Older adults experienced substantial decreases in life-space mobility during the COVID-19 pandemic, and this unexpected change impacted their QoL. Providers should be particularly watchful for the consequences of abrupt life-space restrictions on frail individuals.
Palavras-chave
Frailty, life-space mobility, quality of life, COVID-19, quarantine
URI
https://observatorio.fm.usp.br/handle/OPI/40609
Referências
  1. Al Snih S, 2012, J AM GERIATR SOC, V60, P532, DOI 10.1111/j.1532-5415.2011.03822.x
  2. Apolinario D, 2016, INT J GERIATR PSYCH, V31, P4, DOI 10.1002/gps.4282
  3. Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x
  4. Berg-Weger M, 2020, J NUTR HEALTH AGING, V24, P456, DOI 10.1007/s12603-020-1366-8
  5. Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204
  6. Boyle PA, 2010, J AM GERIATR SOC, V58, P1925, DOI 10.1111/j.1532-5415.2010.03058.x
  7. Crowe M, 2008, J GERONTOL A-BIOL, V63, P1241, DOI 10.1093/gerona/63.11.1241
  8. de Boer AGEM, 2004, QUAL LIFE RES, V13, P311, DOI 10.1023/B:QURE.0000018499.64574.1f
  9. Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
  10. Poco PCE, 2021, J GERONTOL A-BIOL, V76, pE46, DOI 10.1093/gerona/glaa280
  11. Fathi R, 2017, J AM GERIATR SOC, V65, P1004, DOI 10.1111/jgs.14739
  12. Fayers PM, 2002, J ROY STAT SOC A STA, V165, P233, DOI 10.1111/1467-985X.02020
  13. Flint L, 2020, ANN INTERN MED, V173, P486, DOI 10.7326/M20-1982
  14. Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
  15. Galenkamp H, 2013, GERIATR GERONTOL INT, V13, P678, DOI 10.1111/j.1447-0594.2012.00963.x
  16. Garnier-Crussard A, 2020, J AM GERIATR SOC, V68, P939, DOI 10.1111/jgs.16407
  17. GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619
  18. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  19. Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574
  20. Jacobs JM, 2018, J AM GERIATR SOC, V66, P106, DOI 10.1111/jgs.15148
  21. KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K
  22. Kennedy RE, 2019, J AM GERIATR SOC, V67, P565, DOI 10.1111/jgs.15707
  23. Kennedy RE, 2019, J AGING HEALTH, V31, P280, DOI 10.1177/0898264317730487
  24. Kennedy RE, 2017, J AM GERIATR SOC, V65, P833, DOI 10.1111/jgs.14738
  25. Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
  26. Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613
  27. Lee SJ, 2007, J AM GERIATR SOC, V55, P1624, DOI 10.1111/j.1532-5415.2007.01360.x
  28. Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
  29. Lo AX, 2014, J AM GERIATR SOC, V62, P919, DOI 10.1111/jgs.12787
  30. Mackey DC, 2016, J AM GERIATR SOC, V64, P2226, DOI 10.1111/jgs.14474
  31. Mackey DC, 2014, J AM GERIATR SOC, V62, P1288, DOI 10.1111/jgs.12892
  32. Matsudo S., 2001, REV BRAS ATIV FIS SA, V6, P5, DOI 10.12820/RBAFS.V.6N2P5-18
  33. Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2
  34. Morley JE, 2020, J NUTR HEALTH AGING, V24, P364, DOI 10.1007/s12603-020-1349-9
  35. Nelson LM, 2020, JAMA INTERN MED, V180, P1020, DOI 10.1001/jamainternmed.2020.1369
  36. Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008
  37. Portegijs E, 2016, AGE AGEING, V45, P550, DOI 10.1093/ageing/afw072
  38. Rantakokko M, 2016, QUAL LIFE RES, V25, P1189, DOI 10.1007/s11136-015-1137-x
  39. Rantakokko M, 2013, J AM GERIATR SOC, V61, P1830, DOI 10.1111/jgs.12473
  40. Aliberti MJR, 2021, AGE AGEING, V50, P32, DOI 10.1093/ageing/afaa240
  41. Roschel H, 2020, J AM GERIATR SOC, V68, P1126, DOI 10.1111/jgs.16550
  42. Saraiva MD, 2020, BMC GERIATR, V20, P1, DOI [10.1186/s12877-019-1374-x, DOI 10.1186/S12877-019-1374-X]
  43. Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631
  44. Sepulveda-Loyola W, 2020, J NUTR HEALTH AGING, DOI [10.1007/s12603-020-1469-2, 10.1007/s12603-020-1500-7]
  45. Sheppard KD, 2013, J AGING HEALTH, V25, P907, DOI 10.1177/0898264313497507
  46. Silberschmidt S, 2017, J AM GERIATR SOC, V65, P1514, DOI 10.1111/jgs.14829
  47. Simoes MDMP, 2018, GERIATR GERONTOL INT, V18, P783, DOI 10.1111/ggi.13263
  48. Steinman MA, 2020, JAMA INTERN MED, V180, P819, DOI 10.1001/jamainternmed.2020.1661
  49. Wallace Meredith, 2007, Urol Nurs, V27, P93
  50. Xue QL, 2008, AM J EPIDEMIOL, V167, P240, DOI 10.1093/aje/kwm270
  51. Yamada M, 2020, J NUTR HEALTH AGING, DOI [10.1007/s12603-020-1424-2, 10.1007/s12603-020-1501-6]

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Carregar mais